A biopharma CEO opens up about executive salaries — and why he wants to change the status quo

With leaders at the biggest biopharma companies bringing in millions, the CEO of Corvus Pharmaceuticals opted for a pay cut to pour more funds into science.

By Michael Gibney • May 4, 2023

Attracting up-and-coming talent in biotech

The CEO of a Bay-area startup shares his strategies for growing a team from the ground up.

By Meagan Parrish • May 3, 2023

Explore the Trendline➔

Clinical trial diversity

As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

By PharmaVoice staff

Woman of the Week: Jazz Pharmaceuticals’ Neena Patil

Patil’s dual interests in healthcare and law are at the intersection of her C-suite role.

By Taren Grom • May 3, 2023

From science to strategy, this exec is painting Genmab’s bigger picture into the next decade

Martine van Vugt, recently named Genmab’s chief strategy officer and executive vice president, aims to usher in the company’s next wave of "knock your socks off" antibodies.

By Michael Gibney • May 2, 2023

A CEO’s quest to solve a 400-year-old medical mystery — and he’s also a patient

The CEO of Ventoux Biosciences has the disease that his company is aiming to treat, and it's driving him to find better medications.

By Taren Grom • May 1, 2023

BMS’s CEO transition will be a major test for the pharma giant

Come November, Chris Boerner will take the top spot as the company approaches patent cliffs for three drugs in the next decade.

By Karissa Waddick • April 28, 2023

5 minutes with — DTRA’s Dr. Amir Kalali

An industry veteran, innovator and curator, Dr. Amir Kalali discusses the high points of his career and his go-to productivity hack.

By Taren Grom • April 28, 2023

Pharma’s immunology field is full of blockbusters, and it’s just getting started

From the "father" of the IL-23 pathway at Janssen to a big acquisition by Merck, the ultra-competitive immunology space is still growing with the pace of innovation.

By Michael Gibney • April 27, 2023

Roy Vagelos is retiring and leaving a legacy of leadership lessons

The longtime pharma leader is stepping down from his role as chair of Regeneron’s board in June after decades in drug development. 

By Karissa Waddick • April 25, 2023

The 99 seconds that changed this CEO’s life

Peter Kirk’s marathon story of inspiration and perseverance.

By Taren Grom • April 21, 2023

Cure Ventures has $350M to pour deep into biotech ‘company building’

The biotech venture capital firm Cure Ventures, led by three industry veterans, raised the inaugural fund in early April and will soon announce its seed companies.

By Michael Gibney • April 20, 2023

Conditions for worker burnout in biotech are ripe. Here’s how to beat it

One of the country’s leading burnout experts explains how companies can help keep high stress from becoming a high desire to leave the job.

By Meagan Parrish • April 19, 2023

Woman of the Week: Brii Biosciences’ Ellee de Groot

A chemical engineer by training, Brii’s chief technology officer is applying her experience to solve research problems from the clinic to commercial development.

By Taren Grom • April 19, 2023

Fighting vaccine hesitancy may require a new approach from pharma

The COVID-19 pandemic highlighted an ongoing problem of vaccine hesitancy undermining public health efforts. One way pharmas can help is to change the narrative.

By Michael Gibney • April 13, 2023

Woman of the Week: uMotif’s Julia Lakeland

The chief product officer’s work in transforming clinical trial technology is driven by people.

By Taren Grom • April 12, 2023

He helped launch the Pfizer COVID vaccine — now this startup CEO is hunting a lingering pandemic foe

All of the COVID-19 mAbs have been pulled from the market. But Dave Hering, CEO of Invivyd, hopes to change that.

By Meagan Parrish • April 11, 2023

5 minutes with — Parexel’s Peyton Howell

The company’s chief operating and growth officer on her personal quirks and why every pharma leader should read "Getting Naked."

By Taren Grom • April 7, 2023

Despite J&J’s exit, Big Pharma is closing in on a launch of the first RSV vax this year

Although Janssen bowed out of the RSV vaccine race, several pharmas are quickly closing in on the finish line in a disease with decades of unmet need.

By Michael Gibney • April 6, 2023

Woman of the Week: Intergalactic Therapeutics’ Dr. Theresa Heah

Welcome to the Woman of the Week podcast, a weekly discussion that illuminates the unique stories of women leaders who are catalyzing change throughout the life sciences industry. You can check out all our podcast episodes here. Dr. Theresa Heah has spent her entire career moving ophthalm...

By Taren Grom • April 5, 2023

Amgen’s aim for a ‘moonshot’ in cardiovascular disease

A VP of global development at Amgen explains how treating general medicine diseases could one day resemble approaches in oncology.  

By Taren Grom • April 5, 2023

Moderna exec: ‘There is nothing but global health’

How Chantal Friebertshäuser is helping lead Moderna’s plan to expand its global reach.  

By Alexandra Pecci • April 4, 2023

Leaders wave a magic wand at pharma’s thorniest issues

The major challenges pharma leaders would solve with a quick flick of an imaginary wand.

By PharmaVoice staff • March 31, 2023

Digital biomarkers lay the groundwork for precision medicine beyond the bloodwork

Biomarkers are the hidden talent behind precision medicine, and finding them doesn't have to always come from a blood test — digital pioneers are finding another way.

By Michael Gibney • March 30, 2023

Woman of the Week: Psilera’s Jackie von Salm

Psilera founder’s “third eye” approach to psychedelics ushers them into the therapeutic realm.

By Taren Grom • March 29, 2023

Seamless clinical trials were created to make studies easier — instead, they’ve become more complex

Experts weigh in on how companies can design better trials that merge two phases into one.

By Meagan Parrish • March 29, 2023